|
Volumn 85, Issue , 2014, Pages 638-647
|
Novel alkylphospholipid-DTC hybrids as promising agents against endocrine related cancers acting via modulation of Akt-pathway
|
Author keywords
Akt pathway; Alkylphospholipid; Anti proliferative agent; Dithiocarbamate; Endocrine cancer; Miltefosine
|
Indexed keywords
2 [DECYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL 4 METHYLPIPERAZINE 1 CARBODITHIOATE;
2 [DECYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL AZEPANE 1 CARBODITHIOATE;
2 [DECYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL PIPERIDINE 1 CARBODITHIOATE;
2 [DECYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL PYRROLIDINE 1 CARBODITHIOATE;
2 [HEXADECYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL 4 METHYLPIPERAZINE 1 CARBODITHIOATE;
2 [HEXADECYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL AZEPANE 1 CARBODITHIOATE;
2 [HEXADECYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL PIPERIDINE 1 CARBODITHIOATE;
2 [HEXYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL 4 METHYLPIPERAZINE 1 CARBODITHIOATE;
2 [HEXYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL AZEPANE 1 CARBODITHIOATE;
2 [HEXYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL PIPERIDINE 1 CARBODITHIOATE;
2 [HEXYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL PYRROLIDINE 1 CARBODITHIOATE;
2 [HYDROXY(OCTYLOXY)PHOSPHORYLOXY]ETHYL 4 METHYLPIPERAZINE 1 CARBODITHIOATE;
2 [HYDROXY(OCTYLOXY)PHOSPHORYLOXY]ETHYL AZEPANE 1 CARBODITHIOATE;
2 [HYDROXY(OCTYLOXY)PHOSPHORYLOXY]ETHYL PIPERIDINE 1 CARBODITHIOATE;
2 [HYDROXY(OCTYLOXY)PHOSPHORYLOXY]ETHYL PYRROLIDINE 1 CARBODITHIOATE;
2 [HYDROXY(PROPOXY)PHOSPHORYLOXY]ETHYL 4 METHYLPIPERAZINE 1 CARBODITHIOATE;
2 [HYDROXY(PROPOXY)PHOSPHORYLOXY]ETHYL AZEPANE 1 CARBODITHIOATE;
2 [HYDROXY(PROPOXY)PHOSPHORYLOXY]ETHYL PIPERIDINE 1 CARBODITHIOATE;
2 [HYDROXY(PROPOXY)PHOSPHORYLOXY]ETHYL PYRROLIDINE 1 CARBODITHIOATE;
ALKYLPHOSPHOLIPID;
ANTINEOPLASTIC AGENT;
DITHIOCARBAMIC ACID;
MILTEFOSINE;
PHOSPHOLIPID DERIVATIVE;
PROTEIN KINASE B;
UNCLASSIFIED DRUG;
DIETHYLDITHIOCARBAMIC ACID;
PHOSPHOLIPID;
2 [HEXADECYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL METHYLPIPERAZINE 1 CARBODITHIOATE;
2 [HEXADECYLOXY(HYDROXY)PHOSPHORYLOXY]ETHYL PYRROLIDINE 1 CARBODITHIOATE;
CYCLIN A1;
CYCLIN A2;
DITHIOCARBAMIC ACID DERIVATIVE;
GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;
ANTINEOPLASTIC ACTIVITY;
ANTIPROLIFERATIVE ACTIVITY;
APOPTOSIS;
ARTICLE;
BREAST CANCER CELL LINE;
CELL CYCLE PROGRESSION;
CONTROLLED STUDY;
DOWN REGULATION;
ENDOCRINE TUMOR;
HUMAN;
HUMAN CELL;
IC 50;
MITOCHONDRIAL MEMBRANE POTENTIAL;
PROSTATE CANCER CELL LINE;
SIGNAL TRANSDUCTION;
STRUCTURE ACTIVITY RELATION;
BREAST TUMOR;
CELL CYCLE;
CHEMISTRY;
DRUG EFFECTS;
DRUG SCREENING;
GENE EXPRESSION REGULATION;
MALE;
METABOLISM;
PATHOLOGY;
PHOSPHORYLATION;
PROSTATE TUMOR;
TUMOR CELL LINE;
CANCER INHIBITION;
CELL GROWTH;
CELL PROLIFERATION;
CYTOTOXICITY;
DRUG SYNTHESIS;
EMBRYO;
G1 PHASE CELL CYCLE CHECKPOINT;
HEK293 CELL LINE;
HUMAN TISSUE;
IC50;
MCF 7 CELL LINE;
PROTEIN PHOSPHORYLATION;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BREAST NEOPLASMS;
CELL CYCLE;
CELL LINE, TUMOR;
DITIOCARB;
DRUG SCREENING ASSAYS, ANTITUMOR;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
MALE;
MEMBRANE POTENTIAL, MITOCHONDRIAL;
PHOSPHOLIPIDS;
PHOSPHORYLATION;
PROSTATIC NEOPLASMS;
PROTO-ONCOGENE PROTEINS C-AKT;
SIGNAL TRANSDUCTION;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84906099891
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2014.08.028 Document Type: Article |
Times cited : (16)
|
References (25)
|